Overview

Fecal Microbiota Transplantation for Epilepsy

Status:
Recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

Increasing evidences showed the microbiota effects on neuropsychiatric disorders. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation for epilepsy.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

The Second Hospital of Nanjing Medical University